Suppr超能文献

成功诱导小型猪对完全异基因肾移植产生长期特异性耐受。

Successful induction of long-term specific tolerance to fully allogeneic renal allografts in miniature swine.

作者信息

Smith C V, Nakajima K, Mixon A, Guzzetta P C, Rosengard B R, Fishbein J M, Sachs D H

机构信息

Transplantation Biology Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

出版信息

Transplantation. 1992 Feb;53(2):438-44. doi: 10.1097/00007890-199202010-00033.

Abstract

Major histocompatibility complex class II matching is of overwhelming importance for achieving tolerance to kidney transplants (KTX) in miniature swine. When class II antigens are matched, long-term specific tolerance across complete MHC class I antigen barriers can uniformly be induced by a 12-day perioperative course of cyclosporine. This same regimen is ineffective in fully MHC-mismatched combinations. We hypothesized that initial induction of tolerance to kidney donor class II antigens by bone marrow transplantation might allow tolerance to be induced to a subsequent fully allogeneic KTX in combination with CsA therapy. We report here the results of such fully allogeneic KTX performed in 4 recipients of prior single-haplotype class II-mismatched BMT. All animals received KTX from donors class II matched to the BMT donor and received a 12-day course of intravenous CsA (10 mg/kg/day). All four animals have maintained normal serum creatinine values (less than 2.0 mg/dl) for greater than 200 days posttransplant. Specific hyporesponsiveness to both BMT and KTX donor-type MHC antigens was found in mixed lymphocyte culture and cell-mediated lympholysis assays. Compared with third-party grafts, significantly prolonged survival of BMT donor-specific (P = 0.031) and KTX donor-specific (P = 0.031) skin grafts was observed. These results demonstrate that induction of tolerance to class II antigens by BMT allows a short course of CsA to induce specific tolerance to fully allogeneic renal allografts.

摘要

主要组织相容性复合体II类匹配对于在小型猪中实现肾移植(KTX)耐受性至关重要。当II类抗原匹配时,通过12天的围手术期环孢素疗程可一致地诱导跨越完整MHC I类抗原屏障的长期特异性耐受。相同方案在完全MHC不匹配的组合中无效。我们假设通过骨髓移植最初诱导对肾供体II类抗原的耐受性可能允许与环孢素A疗法联合诱导对随后的完全异基因KTX的耐受性。我们在此报告在4例先前单倍型II类不匹配骨髓移植受者中进行的这种完全异基因KTX的结果。所有动物接受来自与骨髓移植供体II类匹配的供体的KTX,并接受12天的静脉内环孢素A疗程(10mg/kg/天)。所有四只动物在移植后200多天内维持正常血清肌酐值(低于2.0mg/dl)。在混合淋巴细胞培养和细胞介导的淋巴细胞溶解试验中发现对骨髓移植和KTX供体型MHC抗原均有特异性低反应性。与第三方移植物相比,观察到骨髓移植供体特异性(P = 0.031)和KTX供体特异性(P = 0.031)皮肤移植物的存活时间显著延长。这些结果表明,通过骨髓移植诱导对II类抗原的耐受性允许短疗程的环孢素A诱导对完全异基因肾移植的特异性耐受。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验